Toronto, Ontario–(Newsfile Corp. – February 15, 2022) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “ Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the key results from the 90-day oral toxicity preclinical study on its proprietary extract of the Amanita…


Previous articlePT293 – Stanislav & Brigitte Grof – The Evolution of Breathwork and The Psychology of the Future
Next articleatai Life Sciences to Participate in Upcoming February Investor Conference